Overall, our studies show that frequencies of caspase-3 expressing antigen-specific CD4+ T cells may reflect mycobacterial burden in vivo and could, therefore, be useful for assessing anti-TB treatment response along with other host biomarkers (50–53). The gene discussed is CD4; the disease is tuberculosis.